Oncotelic Therapeutics, Inc. Convertible Debt, Current
Oncotelic Therapeutics, Inc. (OTLC) had Convertible Debt, Current of $1.67 million as of 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2022-04-15
- 2021-12-31: Convertible Debt, Current $1.67M.
- 2021-09-30: Convertible Debt, Current $1.94M.
- 2021-06-30: Convertible Debt, Current $1.66M.
- 2021-03-31: Convertible Debt, Current $958.88K.
| Period end | Convertible Debt, Current |
|---|---|
| 2021-12-31 | $1.67M 10-K · filed 2022-04-15 |
| 2021-09-30 | $1.94M 10-Q · filed 2021-11-22 |
| 2021-06-30 | $1.66M 10-Q · filed 2021-08-20 |
| 2021-03-31 | $958.88K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $1.09M 10-K · filed 2022-04-15 |
| 2020-09-30 | $1.02M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.22M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.10M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $944.45K 10-K · filed 2021-04-15 |
| 2019-09-30 | $450.29K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $227.93K 10-Q · filed 2019-08-19 |